0001193125-16-579902.txt : 20160505 0001193125-16-579902.hdr.sgml : 20160505 20160505161238 ACCESSION NUMBER: 0001193125-16-579902 CONFORMED SUBMISSION TYPE: 15-12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160505 DATE AS OF CHANGE: 20160505 EFFECTIVENESS DATE: 20160505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BG Medicine, Inc. CENTRAL INDEX KEY: 0001407038 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 043506204 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-33827 FILM NUMBER: 161623817 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET STREET 2: SUITE 210 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-1199 MAIL ADDRESS: STREET 1: 880 WINTER STREET STREET 2: SUITE 210 CITY: WALTHAM STATE: MA ZIP: 02451 15-12B 1 d119910d1512b.htm 15-12B 15-12B

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 001-33827

 

 

BG MEDICINE, INC.

(Exact name of registrant as specified in its charter)

 

 

303 Wyman Street, Suite 300

Waltham, Massachusetts 02451

(781) 890-1199

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock (par value $0.001 per share)

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

   Rule 12g-4(a)(1)    x   
   Rule 12g-4(a)(2)    ¨   
   Rule 12h-3(b)(1)(i)    x   
   Rule 12h-3(b)(1)(ii)    ¨   
   Rule 15d-6    ¨   
   Rule 15d-22(b)    ¨   

Approximate number of holders of record as of the certification or notice date: 29.

Pursuant to the requirements of the Securities Exchange Act of 1934, BG Medicine, Inc. has caused this Certification and Notice to be signed on its behalf by the undersigned duly authorized person.

Date: May 5, 2016

 

BG MEDICINE, INC.
By:  

/s/ Paul R. Sohmer, M.D.

  Name:   Paul R. Sohmer, M.D.
  Title:   President and Chief Executive Officer